Starling Oncology, Inc. Other Sundry Liabilities, Current
Starling Oncology, Inc. (DFPH) had Other Sundry Liabilities, Current of $6.24 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:OtherSundryLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Sundry Liabilities, Current $6.24M.
- 2026-03-31: Other Sundry Liabilities, Current $5.67M.
- 2025-12-31: Other Sundry Liabilities, Current $4.30M.
- 2025-09-30: Other Sundry Liabilities, Current $4.71M.
| Period end | Other Sundry Liabilities, Current | Other Sundry Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.24M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $5.67M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $4.30M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $4.71M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.62M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $7.63M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $5.31M 10-Q · filed 2025-11-13 | $6.48M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $5.45M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $5.36M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $7.08M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.60M 10-Q · filed 2024-11-13 | |
| 2023-09-30 | $2.62M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $6.12M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.51M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $3.23M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $2.98M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.42M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $3.00M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.97M 10-K · filed 2023-03-16 | $2.64M 10-K · filed 2022-03-11 |
| 2020-12-31 | $1.81M 10-K · filed 2022-03-11 |